A 63-year-old woman with Type 2 diabetes is seen for follow-up after a fasting lipid profile. She has no other medical conditions and feels well. Her diabetes is well controlled and the last hemoglobin A1C value was 6.5%. Her total cholesterol (T-chol) is 240 mg/dL, HDL50 mg/dL, low-density lipoprotein (LDL) 160 mg/dL, and triglycerides 150 mg/dL.For the above patient with dyslipidemia, select the most appropriate treatment.
fibric acid derivatives (clofibrate, gemfibrozil) nicotinic acid bile acid-binding resins (cholestyramine, colestipol) hepatic hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (lovastatin, simvastatin, pravastatin)